D’Avanzo, Barbara
Barbato, Angelo
Monzio Compagnoni, Matteo
Caggiu, Giulia
Allevi, Liliana
Carle, Flavia
Di Fiandra, Teresa
Ferrara, Lucia
Gaddini, Andrea
Sanza, Michele
Saponaro, Alessio
Scondotto, Salvatore
Tozzi, Valeria D
Giordani, Cristina
Corrao, Giovanni
Lora, Antonio
Funding for this research was provided by:
UniversitĂ degli Studi di Milano - Bicocca
Article History
Received: 22 February 2023
Accepted: 31 May 2023
First Online: 13 June 2023
Declarations
:
: GC received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry for University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as member of Advisory Board from Roche. No other potential conflicts of interest relevant to this article were disclosed.
: All methods were carried out in accordance with the Declaration of Helsinki. The Ethical Committee of the University of Milano-Bicocca approved the study protocol (Protocol number 497, Year 2019) and established that the study. Informed consent was waived by the Ethical Committee of the University of Milano-Bicocca.
: Not applicable.